Simvastatin to improve symptoms, cognition, metabolic syndrome and movement disorders in patients with recent-onset psychotic disorder.
Purpose of the study
To evaluate whether simvastatin addition improves symptoms, cognition, metabolic syndrome and movement disorders in patients with recent-onset psychotic disorder.